@max_gomez reports remarkable improvement in first US glioma patient who has completed his first #EnGeneIC EDV treatment cycle. Well done to @johnboovkvar’s team @lenoxhill hospital. https://t.co/ntyOmZyq5e
We are currently enrolling #GBM patients for our EnGeneIC Dream Vector (EDVTM) nanocell-based technology, a new way of delivering chemotherapy drugs for the treatment of #braintumors. https://t.co/EUGTQusUoq @LenoxNeurosurg@NorthwellHealth 4 info please contact @ShereseFralin